William D. Waddill, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,868 shares at $38.59 ($300K) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Scheduled sale ($300k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.81 | 2,634 | $100K | 33.3% |
| 2 | $37.81 | 2,634 | $100K | 33.3% |
| 3 | $38.59 | 1,300 | $50K | 16.7% |
| 4 | $38.59 | 1,300 | $50K | 16.7% |
| Total | $38.07 avg | 7,868 | $300K | 100% |
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |